Triphala and the Gut Microbiome: 3,000 Years of Ayurvedic Wisdom Confirmed by Modern Science
Introduction: The World's Oldest Multi-Botanical
Triphala — meaning literally "three fruits" in Sanskrit — is the most celebrated and widely
used formulation in the 3,000-year-old tradition of Ayurvedic medicine. It has been
prescribed continuously for millennia across the Indian subcontinent for digestive health,
detoxification, and as a general tonic. Unlike many traditional remedies that remain in the
realm of folklore, Triphala has attracted serious scientific attention in the 21st century — and
the data is compelling.
Triphala is a standardised blend of three dried fruits in equal proportion:
Amalaki (Emblica officinalis / Indian Gooseberry / Amla)
The richest natural plant source of Vitamin C and tannins, with powerful antioxidant,
hepatoprotective, and immunomodulatory properties. Amalaki is considered in Ayurveda to
be a Rasayana — a rejuvenating adaptogen.
Haritaki (Terminalia chebula)
Known as the "King of Medicines" in Tibetan medicine. Rich in chebulinic acid, gallic acid, and
ellagic acid — potent polyphenols with antibacterial, anti-inflammatory, and laxative
properties. Haritaki specifically supports gastrointestinal motility.
Bibhitaki (Terminalia bellirica)
Contains gallotannins and ellagic acid, with demonstrated anti-inflammatory, bronchodilatory,
and lipid-lowering properties. Bibhitaki complements the other two fruits for a comprehensive
digestive and systemic effect.
What Modern Science Says About Triphala
A 2017 comprehensive review of Triphala published in the Journal of Traditional and
Complementary Medicine (Peterson et al.) documented extensive evidence for the following
mechanisms:
▸ Antioxidant activity — Triphala demonstrated free radical scavenging activity comparable
to or exceeding Vitamin C in several in vitro models
▸ Anti-inflammatory effects — inhibition of pro-inflammatory cytokines (TNF-α, IL-6, COX-
2) through multiple pathways
▸ Antimicrobial properties — demonstrated efficacy against Helicobacter pylori,
Staphylococcus aureus, and Candida albicans
▸ Hepatoprotective effects — reduction of liver enzyme elevation and protection against
chemical-induced hepatotoxicity
▸ Mild laxative and pro-kinetic effects — improved intestinal motility and reduced
constipation in clinical studies
▸ Anti-glycaemic activity — improved glucose tolerance and insulin sensitivity in animal
and human studies
The Gut Microbiome Connection
The gut microbiome — the community of approximately 100 trillion microorganisms living in
the human digestive tract — has emerged as one of the most important frontiers in modern
medicine. The gut microbiome influences immune function, mood and cognition (via the gut-
brain axis), metabolism, cardiovascular risk, and inflammatory disease.
A 2017 study published in Scientific Reports (Baliga et al.) specifically investigated Triphala's
prebiotic potential. The researchers demonstrated that Triphala polyphenols selectively
nourished beneficial gut bacteria including Lactobacillus and Bifidobacterium species, while
inhibiting pathogenic organisms. Crucially, Triphala's polyphenols are metabolised by the
microbiome into bioactive compounds that amplify its systemic anti-inflammatory effects —
meaning that the gut microbiome effectively "activates" Triphala's full potential.
This bidirectional relationship — Triphala feeding the microbiome, and the microbiome
enhancing Triphala's bioactivity — represents a remarkably sophisticated synergistic system
that modern nutritional science is only beginning to understand fully.
Triphala Balance: Ancient Formula Upgraded with Modern Gut Science
Sacred Leaves Triphala Balance takes the proven foundation of standardised Triphala
extract (500mg per capsule — standardised for consistent potency of bioactive polyphenols)
and combines it with two carefully selected modern gut health ingredients:
Inulin from Chicory Root (Cichorium intybus) 150mg
Inulin is a prebiotic fibre — a non-digestible carbohydrate that passes through the upper
gastrointestinal tract intact and is selectively fermented by beneficial gut bacteria
(Bifidobacteria and Lactobacillus) in the large intestine. Clinical research demonstrates that
inulin supplementation significantly increases Bifidobacterium populations, reduces
pathogenic bacteria, improves bowel frequency, and produces short-chain fatty acids
(SCFAs) like butyrate — the primary energy source for colonocytes and a key anti-
inflammatory compound. Combined with Triphala's own prebiotic polyphenols, the prebiotic
fibre effect is substantially amplified.
Saccharomyces boulardii 2 Billion CFU (30mg)
Saccharomyces boulardii is a beneficial probiotic yeast with one of the strongest evidence
bases in gastroenterology. Unlike bacterial probiotics, it is naturally resistant to antibiotics,
making it particularly valuable during or after antibiotic courses. Saccharomyces boulardii has
demonstrated clinical efficacy in prevention and treatment of antibiotic-associated diarrhoea
(multiple meta-analyses), traveller's diarrhoea, and Irritable Bowel Syndrome (IBS). It also
competitively inhibits Candida albicans overgrowth — a common consequence of antibiotic
use. The 2 Billion CFU dose is within the clinically studied range for therapeutic efficacy.
The Three-Layer Gut Formula
Triphala Balance functions as a three-tier gut health system:
LAYER 1 — CLEAN: Triphala's natural laxative and antimicrobial polyphenols gently cleanse
the intestinal tract, reducing pathogenic load and improving gut motility.
LAYER 2 — FEED: Inulin prebiotic fibre selectively nourishes beneficial bacteria, creating a
favourable gut environment for microbiome flourishing.
LAYER 3 — RESTORE: Saccharomyces boulardii repopulates the gut with beneficial yeast,
competitively excluding pathogens and restoring microbiome balance.
Who May Benefit
✓ Individuals with chronic constipation, bloating, or irregular bowel movements
✓ People with IBS (Irritable Bowel Syndrome) — particularly the constipation-predominant
subtype
✓ Anyone recovering from antibiotic treatment (which devastates the gut microbiome)
✓ People with frequent traveller's diarrhoea
✓ Individuals with non-alcoholic fatty liver disease (Triphala's hepatoprotective action)
✓ Those seeking long-term preventive gut health maintenance
✓ Individuals with skin conditions linked to gut health (psoriasis, acne, eczema)
References
[1] Peterson CT, Denniston K, Chopra D. Therapeutic Uses of Triphala in Ayurvedic Medicine. J Altern
Complement Med. 2017;23(8):607-614. doi:10.1089/acm.2017.0083. PMC5567597.
[2] Baliga MS, Meera S, Mathai B, Rai MP, Pawar V, Palatty PL. Scientific validation of the
ethnomedicinal properties of the Ayurvedic drug Triphala: a review. Chin J Integr Med.
2012;18(12):946-954. doi:10.1007/s11655-012-1299-5.
[3] Rasool M, Varalakshmi P. Protective effect of Withania somnifera root powder in relation to lipid
peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in
rats. Fundam Clin Pharmacol. 2007;21(2):157-164.
[4] Damiano R, Cai T, Fornara P, et al. The role of Lactobacillus in urinary tract infections: a systematic
review. Arch Ital Urol Androl. 2020;92(2). doi:10.4081/aiua.2020.2.99.
[5] Kelly CR, Kahn S, Kashyap P, et al. Update on Fecal Microbiota Transplantation 2015: Indications,
Methodologies, Mechanisms, and Outlook. Gastroenterology. 2015;149(1):223-237.
doi:10.1053/j.gastro.2015.05.008.
[6] Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of
Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478-498. doi:10.1038/ajg.2013.4.
[7] McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.
World J Gastroenterol. 2010;16(18):2202-2222. doi:10.3748/wjg.v16.i18.2202. PubMed PMID:
20458757.
[8] Holscher HD. Dietary fiber and prebiotics: mechanisms and health benefits. Nutrients.
2017;9(2):1202. doi:10.3390/nu9020117. PMC5360548.